Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract

Abstract

BackgroundInfections of the ears, paranasal sinuses, nose and throat are very common and represent a serious issue for the healthcare system. Bacterial biofilms have been linked to upper respiratory tract infections and antibiotic resistance, raising serious concerns regarding the therapeutic management of such infections. In this context, novel strategies able to fight biofilms may be therapeutically beneficial and offer a valid alternative to conventional antimicrobials. Biofilms consist of mixed microbial communities, which interact with other species in the surroundings and communicate through signaling molecules. These interactions may result in antagonistic effects, which can be exploited in the fight against infections in a sort of “bacteria therapy”. Streptococcus salivarius and Streptococcus oralis are α-hemolytic streptococci isolated from the human pharynx of healthy individuals. Several studies on otitis-prone children demonstrated that their intranasal administration is safe and well tolerated and is able to reduce the risk of acute otitis media. The aim of this research is to assess S. salivarius 24SMB and S. oralis 89a for the ability to interfere with biofilm of typical upper respiratory tract pathogens.MethodsTo investigate if soluble substances secreted by the two streptococci could inhibit biofilm development of the selected pathogenic strains, co-cultures were performed with the use of transwell inserts. Mixed-species biofilms were also produced, in order to evaluate if the inhibition of biofilm formation might require direct contact. Biofilm production was investigated by means of a spectrophotometric assay and by confocal laser scanning microscopy.ResultsWe observed that S. salivarius 24SMB and S. oralis 89a are able to inhibit the biofilm formation capacity of selected pathogens and even to disperse their pre-formed biofilms. Diffusible molecules secreted by the two streptococci and lowered pH of the medium revealed to be implied in the mechanisms of anti-biofilm activity.ConclusionsS. salivarius 24SMB and S. oralis 89a possess desirable characteristics as probiotic for the treatment and prevention of infections of the upper airways. However, the nature of the inhibition appear to be multifactorial and additional studies are required to get further insights.Electronic supplementary materialThe online version of this article (10.1186/s12879-018-3576-9) contains supplementary material, which is available to authorized users.

Ability of adhesion and biofilm formation of pathogens of periprosthetic joint infections on titanium-niobium nitride (TiNbN) ceramic coatings

“…The obtained images were then processed with the Las X software (Leica Microsystems CMS GmbH, Mannheim, Germany) and analyzed with the Fiji software (Fiji, ImageJ, Wayne Rasband National Institutes of Health). The quantification of the fluorescence signal was performed on each independent channel following a threshold, and the mean intensity of the green and red fluorescence was measured using the Image J software, for the estimation the overall volume, along with the live/dead cells ratio [12].…”

Postbiotics for Preventing and Treating Common Infectious Diseases in Children: A Systematic Review

“…Children younger than 5 years are especially vulnerable to infections; this predisposition is thought to be driven by a complex network of modulators, involving the immaturity of the immune response and organ function [1]. Since early 1980, the use of probiotics has been proposed to reduce the burden of common infectious disease among children [2][3][4][5] and infants [6]. However, a noteworthy part of the scientific community does not support probiotic interventions in younger children, due to rare case reports of probiotic-related infections such as bacteremia, necrotizing enterocolitis, pneumonia, and meningitis [7][8][9][10][11].…”

Targeting Gut Microbial Biofilms—A Key to Hinder Colon Carcinogenesis?

“…These antagonistic compounds have been shown to interfere with biofilm attachment and formation as well as the thinning of mature biofilms. Furthermore, probiotics are capable of competing with the pathogenic bacteria for surface of attachment and nutrients by altering their surrounding pH values [ 122 , 123 ]. Besides the direct interactions between probiotics and the pathogens, probiotics exert immunomodulatory effects via interaction with the immune system when administered into a host.…”